Glytec Receives 510(k) Approval for Diabetes Management Software

Glytec announced its fourth FDA 510(k) clearance, adding additional capabilities to its Glucommander diabetes management system.

The latest approval encompasses a titration module for inpatients undergoing enteral nutrition, an insulin-to-carb ratio titration option for outpatients, more flexible messaging for dose adjustments, and improved workflow capabilities.

The company claims the platform delivers safety improvements and annual savings as high as $20,000 per licensed acute care bed.